About SpiraCheck
SpiraCheck is a company based in London (United Kingdom) founded in 2016. It operates as a B2B. SpiraCheck offers products and services including Multi-Cancer Breath Test. SpiraCheck operates in a competitive market with competitors including Dognostica and Kozhnosys, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spiracheck Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpiraCheck
SpiraCheck offers a comprehensive portfolio of products and services, including Multi-Cancer Breath Test.
Detects cancers early through breath analysis of volatile compounds.
Funding Insights of SpiraCheck
Detailed funding history for SpiraCheck
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpiraCheck
Investment portfolio details for SpiraCheck
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SpiraCheck
Detailed financials for SpiraCheck
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spiracheck Comparisons
Peer comparison for SpiraCheck
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpiraCheck
SpiraCheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dognostica and Kozhnosys, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of canine-assisted cancer screening
|
|
| Locked | Locked | Locked |
Developer of breath analyzers to detect diseases
|
Detailed competitors of SpiraCheck
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spiracheck
Complete news archive for SpiraCheck
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpiraCheck
SpiraCheck was founded in 2016.
SpiraCheck is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
SpiraCheck is a London-based start-up that develops a breath test for early detection of gastrointestinal and other cancers by analyzing volatile organic compounds. As a spin-out from Imperial College, it has completed six clinical trials and is conducting more to enhance cancer survival rates. The test aims to reduce invasive diagnostics and healthcare costs through better prioritization and early diagnosis.
SpiraCheck's top competitors include Kozhnosys and Dognostica.
SpiraCheck offers Multi-Cancer Breath Test.